Trials / Unknown
UnknownNCT05003336
Effects of Xiangshao Granules on Anxiety in Menopausal Women.
Effects of Xiangshao Granules on Anxiety in Menopausal Women: A Multicenter, Randomized, Double-blind, Placebo-controlled Study.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 360 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- Female
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Symptoms of anxiety are prevalent during the menopausal transition and early postmenopause. These symptoms are mainly improved by anti-anxiety agents, which are associated with some adverse effects including dizziness, sleepiness, and constipation and not all patients respond to currently available pharmacological treatments, thus novel agents with fewer side effects are needed. Some studies have shown that traditional Chinese medicine can alleviate menopausal symptoms safely and economically, and improve quality of life. Xiangshao granules reportedly have good curative effects on menopausal symptoms and premenstrual syndrome and exhibit good safety. This study aim to evaluate the efficacy and safety of Xiangshao granule in improving anxiety state of women with menopause syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xiangshao Granules | dissolve 1 sachet (4 g) in water to be drank 3 times a day after meal for 8 weeks |
| DRUG | Xiangshao Granules Placebo | Xiangshao Granules Placebo |
Timeline
- Start date
- 2021-12-23
- Primary completion
- 2023-03-01
- Completion
- 2023-06-01
- First posted
- 2021-08-12
- Last updated
- 2022-12-27
Locations
18 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05003336. Inclusion in this directory is not an endorsement.